Related Experiment Video
Updated: May 14, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2
Ingeborg M M van Leeuwen1, Maureen Higgins, Johanna Campbell
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Nobels väg 16, Stockholm 171 77, Sweden.
Abstract:
Acetylation of C-terminal lysine residues in the p53 tumor suppressor is associated with increased stability and transcription factor activity. The function, protein level, and acetylation of p53 are downregulated by mdm2, which in its turn is inhibited by the p14(ARF) tumor suppressor. Here, we show that p14(ARF) increases the level of p53 acetylated at lysine 382 in a nuclear chromatin-rich fraction. Unexpectedly, this accumulation of p53AcK382 is dramatically enhanced in the presence of ectopic mdm2. In light of these observations, we propose that p14(ARF) increases the binding of p53-mdm2 complexes to chromatin, thereby limiting the access of protein deacetylases to p53. Supporting this notion, we show that p53AcK382 can be deacetylated in the cytoplasm and that sirtuin SirT2 catalyzes this reaction. These results help understand why inhibition of both SirT1 and SirT2 is needed to achieve effective activation of p53 by small-molecule sirtuin inhibitors.
Insights
p14ARF enhances p53 acetylation at lysine 382, particularly when mdm2 is present. This suggests p14ARF sequesters p53-mdm2 complexes on chromatin, preventing deacetylation by enzymes like SirT2.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Acetylation of the p53 tumor suppressor at C-terminal lysine residues enhances its stability and transcriptional activity.
- The p53 protein's function, level, and acetylation are negatively regulated by mdm2, which is itself inhibited by the p14ARF tumor suppressor.
Purpose of the Study:
- To investigate the effect of p14ARF on the acetylation status of p53, specifically at lysine 382.
- To elucidate the mechanism by which p14ARF influences p53 acetylation and stability in the context of mdm2 interaction.
Main Methods:
- Analysis of p53 acetylation levels at lysine 382 in nuclear chromatin-rich fractions.
- Experimental manipulation involving ectopic expression of mdm2 and p14ARF.
- Investigation of p53 deacetylation in cytoplasmic fractions and identification of catalyzing sirtuins.
Main Results:
- p14ARF increases the level of p53 acetylated at lysine 382 (p53AcK382) within the nuclear chromatin-rich fraction.
- The accumulation of p53AcK382 is unexpectedly enhanced in the presence of ectopic mdm2.
- p53AcK382 can be deacetylated in the cytoplasm, a reaction catalyzed by sirtuin SirT2.
Conclusions:
- p14ARF may increase the binding of p53-mdm2 complexes to chromatin, limiting deacetylase access to p53.
- These findings suggest a mechanism where p14ARF promotes p53 acetylation and stability by chromatin sequestration.
- Understanding the role of SirT2 in p53 deacetylation highlights the need to inhibit both SirT1 and SirT2 for effective p53 activation by small-molecule inhibitors.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
Master Transcription Regulators
DNA Damage Can Stall the Cell Cycle

